Skip to main content
. Author manuscript; available in PMC: 2024 Feb 18.
Published in final edited form as: J Infect Dis. 2016 Jan 5;214(2):182–188. doi: 10.1093/infdis/jiv775

Table 2.

Proportion of Participating Households Reporting Tick Encounters or Physician-Diagnosed Tick-borne Disease, by Treatment Group, Study Year, and Study Site

Outcome,
Year(s), Site
Acaricide Placebo P Value
Ticks crawling
 2011 185/762 (24.3) 209/769 (27.2) .19
 2012 139/541 (25.7) 150/518 (29.0) .23
  Overall 324/1303 (24.9) 359/1287 (27.9) .08
   CT 133/474 (28.1) 157/491 (32.0)
   MD 68/319 (21.3) 60/289 (20.8)
   NY 123/510 (24.1) 142/507 (28.0)
Ticks attached
 2011 127/762 (16.7) 145/769 (18.9) .26
 2012 86/541 (15.9) 84/518 (16.2) .89
  Overall 213/1303 (16.3) 229/1287 (17.8) .33
   CT 78/474 (16.5) 103/491 (21.0)
   MD 35/319 (11.0) 30/289 (10.4)
   NY 100/510 (19.6) 96/507 (18.9)
Self-reported illness
 2011 27/739 (3.7) 25/755 (3.3) .72
 2012 14/534 (2.6) 14/513 (2.7) .91
  Overall 41/1273 (3.2) 39/1268 (3.0) .78
Verified illness
 2011 13/739 (1.8) 14/755 (1.9) .89
 2012 6/534 (1.1) 6/513 (1.2) .94
  Overall 19/1273 (1.5) 20/1268 (1.6) .90

Data are no. (%) of households with specified characteristics.